Alnylam Pharmaceuticals Reports Third Quarter 2015 Financial Results and Highlights from Recent Period

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. MSTR
7. HOOD
8. ABBV
9. LLY
10. DFTX

Go back to Alnylam Pharmaceuticals Reports Third Quarter 2015 Financial Results and Highlights from Recent Period

Alnylam Pharma (ALNY) Reports In-Line Q3 EPS

November 9, 2015 7:13 AM EST

Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($0.91), in-line with the analyst estimate of ($0.91). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $7.55 million.

"The past quarter and recent period were marked by tremendous progress in our efforts to... More